Translating Immuno-Oncology into Health Actions

Cancer IO is a cancer immun­o­therapy focused top-level col­lab­or­ative research and innov­ation project that starts as a part of the Business Finland’s Per­son­alized Health Program.

Cancer IO is a Uni­versity of Hel­sinki coordinated project that integ­rates immuno-oncology (IO) activ­ities at the Uni­ver­sities of Hel­sinki and Turku, 4 Uni­versity hos­pitals and one central hos­pital, 11 Finnish small or medium enter­prises, 3 cancer patient organ­iz­a­tions and the 10 largest IO-investing phar­ma­ceutical companies.